Prescient Therapeutics Limited (AU:PTX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Prescient Therapeutics Limited’s 2024 Annual General Meeting saw the approval of key resolutions, including the election of Dr. Gavin Shepherd and Dr. James Campbell as directors, and the issuance of options to Dr. Shepherd. However, the proposal for a 10% placement facility was not carried, showcasing a significant shareholder dissent.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.